Concepedia

Harry B. Marr

HB

Statistics

Publications

9

Citations

620

H-Index

9

Active since

1979

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Cardiff University

Rega Institute for Medical Research

KU Leuven

Harry B. Marr is an author at Research Triangle Park Foundation specializing in medicinal chemistry, pharmacology, and molecular pharmacology.

Publications per year

1979–2011

9

Publications

9

Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064

Adwoa Akwabi-Ameyaw, Jonathan Y. Bass, Richard D. Caldwell et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 139 citations · Full text

, , +13

Application of Phosphoramidate Pronucleotide Technology to Abacavir Leads to a Significant Enhancement of Antiviral Potency

Christopher McGuigan, Sarah Harris, Susan M. Daluge et al. · Journal of Medicinal Chemistry · 2005 · 94 citations

, , +14

Testicular steroidogenesis after human chorionic gonadotropin desensitization in rats.

Fred I. Chasalow, Harry B. Marr, F. Haour et al. · Journal of Biological Chemistry · 1979 · 93 citations · Full text

, , +17

FXR agonist activity of conformationally constrained analogs of GW 4064

Adwoa Akwabi-Ameyaw, Jonathan Y. Bass, Richard D. Caldwell et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 61 citations · Full text

, , +14

Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene

Jonathan Y. Bass, Justin A. Caravella, Lihong Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 60 citations · Full text

, , +14

1–5 of 9